Article
Choice of biologics in asthma endotypes.
Current opinion in allergy and clinical immunology - 1 Feb 2021
Wangberg Hannah, Woessner Katharine
Abstract excerpt
PURPOSE OF REVIEW: The aim of this study was to highlight the phenotypes and endotypes of asthma as a tool for selection of the Food and Drug Administration approved biologic therapies. RECENT FINDINGS: An evolving concept of asthma has led to the identification of distinct phenotypes and endotypes in this disease. Asthma endotypes are defined as the biological mechanism and are often categorized as T2-high and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
